Home > Insider Trading > Filing (0001365916-22-000125)

Filing Details

Accession Number:: 0001365916-22-000125
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-19 21:00:06
Reporting Period:: 2022-09-15

Accepted Time:: 2022-09-19 21:00:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1365916	Amyris Inc.	AMRS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1227255	Frank Kung	C/O Amyris, Inc. 5885 Hollis Street, Suite 100 Emeryville CA 94608		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-09-15	1,132,333	$4.20	2,055,185	No	4	S	Indirect	by Vivo Opportunity Fund Holdings, LP
Common Stock	Disposition	2022-09-15	252,667	$4.20	458,591	No	4	S	Indirect	by Vivo Capital Fund IX, LP
Common Stock	Disposition	2022-09-16	681,117	$3.60	1,374,068	No	4	S	Indirect	by Vivo Opportunity Fund Holdings, LP
Common Stock	Disposition	2022-09-16	151,983	$3.60	306,608	No	4	S	Indirect	by Vivo Capital Fund IX, LP
Common Stock	Disposition	2022-09-19	883,528	$3.80	490,540	No	4	S	Indirect	by Vivo Opportunity Fund Holdings, LP
Common Stock	Disposition	2022-09-19	197,148	$3.80	109,460	No	4	S	Indirect	by Vivo Capital Fund IX, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	by Vivo Opportunity Fund Holdings, LP
No	4	S	Indirect	by Vivo Capital Fund IX, LP
No	4	S	Indirect	by Vivo Opportunity Fund Holdings, LP
No	4	S	Indirect	by Vivo Capital Fund IX, LP
No	4	S	Indirect	by Vivo Opportunity Fund Holdings, LP
No	4	S	Indirect	by Vivo Capital Fund IX, LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,796,205	Indirect	by Vivo Capital Fund VIII, L.P.
Common Stock	938,416	Indirect	by Vivo Capital Surplus Fund VIII, L.P.
Common Stock	16,207	Indirect	by Vivo Capital LLC
Common Stock	80,000	Direct

Footnotes

The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by each of Vivo Capital Fund IX, L.P. and Vivo Opportunity Fund Holdings, L.P. on August 15, 2022.
The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $3.60 to $4.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The General Partner of Vivo Opportunity Fund Holdings, L.P. is Vivo Opportunity, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The General Partner of Vivo Capital Fund IX, L.P. is Vivo Capital IX, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with six (6) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $3.50 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $3.40 to $4.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.
The General Partner of Vivo Capital Fund VIII, L.P. and Vivo Capital Surplus Fund VIII, L.P. is Vivo Capital VIII, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
Pursuant to an agreement dated November 2, 2017 between the Reporting Person and Vivo Capital LLC ("Vivo Capital"), the Reporting Person agreed to remit the equity compensation received under Issuer's non-employee director compensation program to Vivo Capital if and when such equity compensation becomes vested and/or exercised.